What is the best second-line treatment of advanced renal cell carcinoma (RCC)?

Renal Cell Carcinoma | Investigator Perspectives on Available Research Findings and Challenging Q...Подробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее

Kidney Cancer Conference Highlights from ASCO 2023Подробнее

Cohort 1 LITESPARK-003: belzutifan + cabozantinib 1L treatment for advanced RCCПодробнее

Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer Webcast (2022)Подробнее

Clinical Management of Urothelial Cancer and Renal cell CarcinomaПодробнее

Live Webinar - RCC Webinar - 6 PM - 20 AugПодробнее

UROwebinar: Management of Metastatic kidney cancerПодробнее

Optimising treatment for advanced RCC: Journey through a patient caseПодробнее

Kidney Cancer Conference Highlights from ASCO GU 2023Подробнее

10.19.20 Urology COViD Didactics - Treating Metastatic Renal Cell CarcinomaПодробнее

Lenvatinib and Everolimus for Advanced RCCПодробнее

Latest developments in the treatment of mRCCПодробнее

Second-Line Treatment Options for Advanced RCCПодробнее

Navigating Evolving Standards of Care in RCC: Novel Targeted and Immunotherapy OptionsПодробнее

Second-Line Options for Poor-Risk Advanced RCCПодробнее

RCC: Current Applications, Controversies, and Future Use of Immunotherapy and Targeted AgentsПодробнее

Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCCПодробнее

New Frontiers in the Management of Advanced Renal Cell Carcinoma (RCC)Подробнее

Management of First Line Advanced RCC in Era of Immuno-OncologyПодробнее